Manage urinary incontinence in COPD depending on whether it is stress, urge or mixed
Tóm tắt
Từ khóa
Tài liệu tham khảo
Battaglia S, Benfante A, Principe S, et al. Urinary incontinence in chronic obstructive pulmonary disease: a common co-morbidity or a typical adverse effect? Drugs Aging. 2019;36(9):799–806.
World Health Organization. Chronic obstructive pulmonary disease (COPD): fact sheet. 2017. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 2020.
Putcha N, Puhan MA, Hansel NN, et al. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001–2008. COPD. 2013;10(3):324–32.
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.
Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12:26.
Hrisanfow E, Hagglund D. The prevalence of urinary incontinence among women and men with chronic obstructive pulmonary disease in Sweden. J Clin Nurs. 2011;20(13–14):1895–905.
Burge AT, Lee AL, Kein C, et al. Prevalence and impact of urinary incontinence in men with chronic obstructive pulmonary disease: a questionnaire survey. Physiotherapy. 2017;103(1):53–8.
Hirayama F, Lee AH, Binns CW, et al. Urinary incontinence in men with chronic obstructive pulmonary disease. Int J Urol. 2008;15(8):751–3.
Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med. 2008;148(6):449–58.
Panesar K. Drug-induced urinary incontinence. US Pharmacist. 2014;39(8):24–9.
Button BM, Holland AE, Sherburn MS, et al. Prevalence, impact and specialised treatment of urinary incontinence in women with chronic lung disease. Physiotherapy. 2019;105(1):114–9.
Kafri R, Deutscher D, Shames J, et al. Randomized trial of a comparison of rehabilitation or drug therapy for urgency urinary incontinence: 1-year follow-up. Int Urogynecol J. 2013;24(7):1181–9.
Shamliyan T, Wyman JF, Ramakrishnan R, et al. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Ann Intern Med. 2012;156(12):861–74, W301–10.
Herschorn S, Kaplan SA, Sun F, et al. Do patient characteristics predict responsiveness to treatment of overactive bladder with antimuscarinic agents? Urology. 2014;83(5):1023–9.